Boardroom Alpha
Boardroom Alpha
LGL · Current Report (Form 8-K) · Filed March 24, 2026

Lgl Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 24, 2026
Period
Mar 24, 2026
Ticker
LGL
Accession
0001437749-26-009510
Boardroom Alpha · Filing insights

LGL Group schedules 2026 annual meeting for May 12 and an investor briefing on defense tech plans with Legion Capital.

About Lgl Group Inc
Market cap
$46M
1Y TSR
+2.7%
3Y TSR
+14.5%
Board grade
B+
Sector
Technology
CEO
Jason Lamb
Last annual meeting: May 12, 2026 · View full Lgl Group Inc profile →
lglg20260324c_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  March 24, 2026
 
logo.jpg
 
THE LGL GROUP, INC.
(Exact Name of Registrant as Specified in Charter)
     
Delaware
001-00106
38-1799862
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
     
2525 Shader Road, Orlando, FL
32804
(Address of Principal Executive Offices)
(Zip Code)
 
(407) 298-2000
Registrant’s Telephone Number, Including Area Code
 
(Former Name or Former Address, If Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.01  
LGL
 
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 7.01.
Regulation FD Disclosure
 
On March 24, 2026, The LGL Group, Inc. ("LGL Group" or the "Company") issued a press release announcing the Company's 2026 Annual Meeting of Stockholders and an investor meeting to be held on May 12, 2026, where management intends to discuss the Company's plans to build a defense technology platform within LGL Group and the Company's partnership with Legion Capital, a new defense technology investment platform. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.
 
Item 8.01.
Other Events
 
The Board of Directors of the Company has determined that the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") will be held on Tuesday, May 12, 2026, at 8:30 a.m. ET at the Harvard Club of New York City, 35 West 44th Street, New York, New York 10036.
 
Following the 2026 Annual Meeting, management intends to host an investor meeting at 10:00 a.m. ET at the New York Stock Exchange, 11 Wall Street, New York, New York 10005, where management intends to discuss the Company's plans to build a defense technology platform within LGL Group and the Company's partnership with Legion Capital. Additional details regarding the 2026 Annual Meeting, including the record date, matters to be voted upon and attendance procedures, will be set forth in the Company's proxy materials.
 
Item 9.01.
Financial Statements and Exhibits
 
 
(d)
Exhibits
 
Exhibit No.
Description
   
99.1
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
THE LGL GROUP, INC.
  (Registrant)
   
Date: March 24, 2026
By:
/s/ Patrick Huvane
   
Name:
Patrick Huvane
   
Title:
Executive Vice President - Business Development
 
 
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Lgl Group Inc (LGL)

Reference

Frequently asked questions

When did Lgl Group Inc file this 8-K?
Lgl Group Inc (LGL) filed this Current Report (Form 8-K) with the SEC on March 24, 2026. The accession number assigned by EDGAR is 0001437749-26-009510.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
LGL Group schedules 2026 annual meeting for May 12 and an investor briefing on defense tech plans with Legion Capital. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Lgl Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Lgl Group Inc has filed under CIK 61004, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer